UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How Did These Data Get Here? Recommendations for the Analysis of Data From ClinicalTrials.gov

Therapeutic innovation & regulatory science, 2019-09, Vol.53 (5), p.639-640

Durham, Todd A.

2019

Volltextzugriff (PDF)

Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity

American journal of ophthalmology, 2020-11, Vol.219, p.87-100

2020

Volltextzugriff (PDF)

The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene

Investigative ophthalmology & visual science, 2022-03, Vol.63 (3), p.17-17

2022

Volltextzugriff (PDF)

Functional Vision in Patients With Biallelic USH2A Variants

American journal of ophthalmology, 2024-04, Vol.260, p.200-211

2024

Volltextzugriff (PDF)

Baseline Microperimetry and OCT in the RUSH2A Study: Structure−Function Association and Correlation With Disease Severity

American journal of ophthalmology, 2022-12, Vol.244, p.98-116

2022

Volltextzugriff (PDF)

Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years

American journal of ophthalmology, 2023-06, Vol.250, p.103-110

2023

Volltextzugriff (PDF)

Self-Reported Functional Vision in USH2A-Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire

Investigative ophthalmology & visual science, 2024-06, Vol.65 (6), p.5

2024

Volltextzugriff (PDF)

Tissue‐specific genotype–phenotype correlations among USH2A‐related disorders in the RUSH2A study

Human mutation, 2022-05, Vol.43 (5), p.613-624

2022

Volltextzugriff (PDF)

Integrated cardiac safety: assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance

1st ed., 2008

Volltextzugriff (PDF)

Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation

The American journal of cardiology, 2017-11, Vol.120 (10), p.1820-1829

2017

Volltextzugriff (PDF)

Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A)

American journal of medical genetics. Part A, 2021-12, Vol.185 (12), p.3717-3727

2021

Volltextzugriff (PDF)

Meta‐Methodology: Conducting and Reporting Meta‐Analyses

The journal of clinical hypertension (Greenwich, Conn.), 2014-02, Vol.16 (2), p.91-93

2014

Volltextzugriff (PDF)

The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline

Translational vision science & technology, 2020-10, Vol.9 (11), p.9-9

2020

Volltextzugriff (PDF)

Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease

Eye & contact lens, 2017-09, Vol.43 (5), p.287-296

2017

Volltextzugriff (PDF)

Must New Drugs Be Superior to Those Already Available? The Role of Noninferiority Clinical Trials

The journal of clinical hypertension (Greenwich, Conn.), 2015-04, Vol.17 (4), p.319-321

2015

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Four Simulated Colorectal Cancer Screening Interventions, North Carolina

Preventing chronic disease, 2017-02, Vol.14, p.E18-E18, Article 160158

2017

Volltextzugriff (PDF)

Endpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study

Translational vision science & technology, 2024-10, Vol.13 (10), p.15

2024

Volltextzugriff (PDF)

Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness Consortium

Translational vision science & technology, 2021-04, Vol.10 (4), p.23-23

2021

Volltextzugriff (PDF)

Assessing a Drug's Proarrhythmic Liability: An Overview of Computer Simulation Modeling, Nonclinical Assays, and the Thorough QT/QTc Study

Drug information journal, 2011-05, Vol.45 (3), p.357-375

2011

Volltextzugriff (PDF)

Randomization-based nonparametric methods for the analysis of multicentre trials

Statistical methods in medical research, 2005-06, Vol.14 (3), p.281-301

2005

Volltextzugriff (PDF)

Identifying and Overcoming Challenges in Developing Effective Treatments for Usher 1B: A Workshop Report

Translational vision science & technology, 2023-02, Vol.12 (2), p.2-2

2023

Volltextzugriff (PDF)

Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function

American journal of respiratory and critical care medicine, 2011-03, Vol.183 (5), p.627-634

2011

Volltextzugriff (PDF)

Individual Differences in Cardiovascular Response to Stress

1, 1992

Volltextzugriff (PDF)

Can novel competing risks prediction models improve population health in adults with newly diagnosed atrial fibrillation?

Durham, Todd A

2016

Volltextzugriff (PDF)

Integrated cardiac safety: assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance

2009

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(99)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(113)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(53)
Humans
(42)
Female
(21)
Male
(21)
Adult
(14)
Middle Aged
(14)
Ophthalmology
(14)
Retinitis Pigmentosa
(10)
Aged
(9)
Adolescent
(8)
Mutation
(8)
Usher Syndromes - Genetics
(8)
Double-Blind Method
(7)
Extracellular Matrix Proteins - Genetics
(7)
Treatment Outcome
(7)
Animals
(6)
Clinical Trials
(6)
Medicine
(6)
Retina
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

How Did These Data Get Here? Recommendations for the Analysis of Data From ClinicalTrials.gov

Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity

The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene

Functional Vision in Patients With Biallelic USH2A Variants

Baseline Microperimetry and OCT in the RUSH2A Study: Structure−Function Association and Correlation With Disease Severity

Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years

Self-Reported Functional Vision in USH2A-Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire

Tissue‐specific genotype–phenotype correlations among USH2A‐related disorders in the RUSH2A study

Integrated cardiac safety: assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance

Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation

Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A)

Meta‐Methodology: Conducting and Reporting Meta‐Analyses

The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline

Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease

Must New Drugs Be Superior to Those Already Available? The Role of Noninferiority Clinical Trials

Cost-Effectiveness Analysis of Four Simulated Colorectal Cancer Screening Interventions, North Carolina

Endpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study

Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness Consortium

Assessing a Drug's Proarrhythmic Liability: An Overview of Computer Simulation Modeling, Nonclinical Assays, and the Thorough QT/QTc Study

Randomization-based nonparametric methods for the analysis of multicentre trials

Identifying and Overcoming Challenges in Developing Effective Treatments for Usher 1B: A Workshop Report

Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function

Individual Differences in Cardiovascular Response to Stress

Can novel competing risks prediction models improve population health in adults with newly diagnosed atrial fibrillation?

Integrated cardiac safety: assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance

Suchergebnisse filtern